Medirom Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Medirom Healthcare Technologies
MRM Stock  USD 1.73  0.02  1.17%   
Medirom Healthcare's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Medirom Healthcare's valuation are provided below:
Gross Profit
2 B
Profit Margin
0.005
Market Capitalization
13.5 M
Enterprise Value Revenue
0.7458
Revenue
8.1 B
There are over one hundred nineteen available fundamental ratios for Medirom Healthcare, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to check Medirom Healthcare's last-minute fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 22nd of January 2026, Enterprise Value is likely to grow to about 7.9 B, while Market Cap is likely to drop about 904.1 M.

Medirom Healthcare Total Revenue

6 Billion

Check Medirom Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medirom Healthcare's main balance sheet or income statement drivers, such as Interest Income of 8.7 K, Depreciation And Amortization of 350.2 M or Interest Expense of 60.1 M, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.0 or PTB Ratio of 0.84. Medirom financial statements analysis is a perfect complement when working with Medirom Healthcare Valuation or Volatility modules.
  
Build AI portfolio with Medirom Stock
Check out the analysis of Medirom Healthcare Correlation against competitors.

Medirom Healthcare Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.7 B9.3 B5.6 B
Slightly volatile
Short and Long Term Debt Total3.4 B4.6 B3.1 B
Slightly volatile
Other Current Liabilities1.6 B851.3 M1.2 B
Slightly volatile
Total Current Liabilities3.4 B4.8 B2.9 B
Slightly volatile
Other Liabilities832.5 M1 B736.8 M
Slightly volatile
Property Plant And Equipment Net2.5 B2.9 B2.3 B
Slightly volatile
Current Deferred Revenue393.3 M416.9 M495.9 M
Pretty Stable
Net Debt2.8 B4.2 B2.7 B
Slightly volatile
Accounts Payable1.2 B1.2 B320.2 M
Slightly volatile
Cash408.8 M296.5 M351.5 M
Slightly volatile
Non Current Assets Total4.7 B6.2 B4.1 B
Slightly volatile
Non Currrent Assets Other793.8 M876.1 M1 B
Slightly volatile
Other Assets682 M969.6 M1 B
Slightly volatile
Long Term Debt765.8 M878.8 M544.7 M
Slightly volatile
Cash And Short Term Investments427.5 M302 M378.1 M
Pretty Stable
Net Receivables2.4 B2.3 B727.7 M
Slightly volatile
Good Will362.4 M447.5 M213.4 M
Slightly volatile
Common Stock Total Equity740.5 M1.4 B635 M
Slightly volatile
Common Stock Shares Outstanding5.4 M6.7 M5 M
Slightly volatile
Short Term Investments5.3 M5.5 M24.3 M
Slightly volatile
Liabilities And Stockholders Equity6.7 B9.3 B5.6 B
Slightly volatile
Non Current Liabilities Total2.9 B3.1 B2.5 B
Slightly volatile
Capital Lease Obligations2.1 B2.4 B2.1 B
Very volatile
Inventory183.1 M174.4 M50.2 M
Slightly volatile
Other Current Assets347.1 M195.5 M398.8 M
Very volatile
Other Stockholder Equity579.7 M316.4 M520.7 M
Slightly volatile
Total Liabilities6.3 B7.9 B5.4 B
Slightly volatile
Net Invested Capital3.4 B3.2 B1.2 B
Slightly volatile
Long Term Investments54 M100.5 M53.8 M
Slightly volatile
Property Plant And Equipment Gross2.4 B3.3 B2.3 B
Pretty Stable
Short and Long Term Debt1.3 B1.3 B518.4 M
Slightly volatile
Total Current Assets2 B3.1 B1.5 B
Slightly volatile
Capital Stock553 M317.4 M451.2 M
Slightly volatile
Non Current Liabilities Other195.9 M291.6 M105.3 M
Slightly volatile
Short Term Debt1.3 B2.2 B1.2 B
Slightly volatile
Intangible Assets1.4 B1.3 B376.6 M
Slightly volatile
Common Stock553 M317.4 M451.2 M
Slightly volatile
Property Plant Equipment1.7 B2 B2.2 B
Slightly volatile
Deferred Long Term Liabilities46 M51.8 M56.5 M
Slightly volatile

Medirom Healthcare Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income8.7 K9.2 K1 M
Very volatile
Depreciation And Amortization350.2 M333.5 M121.7 M
Slightly volatile
Interest Expense60.1 M57.2 M23 M
Slightly volatile
Selling General Administrative1.6 B2.4 B1.2 B
Slightly volatile
Selling And Marketing Expenses127.3 M178.7 M100.3 M
Slightly volatile
Total Revenue6 B9.5 B4.8 B
Slightly volatile
Gross Profit1.5 B2.6 B1.2 B
Slightly volatile
Other Operating Expenses6.2 B9.6 B4.8 B
Slightly volatile
Cost Of Revenue4.5 B7 B3.5 B
Slightly volatile
Total Operating Expenses1.7 B2.6 B1.3 B
Slightly volatile
Reconciled Depreciation350.2 M333.5 M118.5 M
Slightly volatile
Research Development10.8 M12.1 M13.2 M
Slightly volatile

Medirom Healthcare Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow116.2 M122.3 M323.5 M
Pretty Stable
Depreciation350.2 M333.5 M120.2 M
Slightly volatile
Capital Expenditures682 M649.5 M156.3 M
Slightly volatile
End Period Cash Flow408.8 M296.5 M351.5 M
Slightly volatile
Change To Netincome369.5 M351.9 M150.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.110.09971.5368
Slightly volatile
Days Sales Outstanding83.1979.2340.2191
Slightly volatile
Stock Based Compensation To Revenue0.03440.03270.0168
Slightly volatile
Capex To Depreciation1.841.750.9296
Slightly volatile
EV To Sales0.590.622.1541
Slightly volatile
Inventory Turnover43.6145.9283
Slightly volatile
Days Of Inventory On Hand8.648.233.2856
Slightly volatile
Payables Turnover6.526.8619.0863
Very volatile
Sales General And Administrative To Revenue0.210.230.2367
Slightly volatile
Capex To Revenue0.06430.06130.0213
Slightly volatile
Cash Per Share12975.5584.7387
Slightly volatile
Days Payables Outstanding57.855.0425.3326
Slightly volatile
Intangibles To Total Assets0.0960.170.0781
Slightly volatile
Current Ratio0.460.580.4844
Slightly volatile
Receivables Turnover4.534.7711.3298
Slightly volatile
Graham Number161311148
Slightly volatile
Capex Per Share10499.5327.5273
Slightly volatile
Revenue Per Share8911.5 K939
Slightly volatile
Interest Debt Per Share511706620
Slightly volatile
Debt To Assets0.560.48910.5718
Slightly volatile
Operating Cycle91.8387.4643.5047
Slightly volatile
Days Of Payables Outstanding57.855.0425.3326
Slightly volatile
Long Term Debt To Capitalization0.950.521.157
Slightly volatile
Total Debt To Capitalization1.020.930.9899
Slightly volatile
Quick Ratio0.450.550.4736
Slightly volatile
Net Income Per E B T1.62.811.425
Slightly volatile
Cash Ratio0.08610.09060.1263
Pretty Stable
Cash Conversion Cycle18.3832.4217.2515
Slightly volatile
Days Of Inventory Outstanding8.648.233.2856
Slightly volatile
Days Of Sales Outstanding83.1979.2340.2191
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.81.280.8912
Slightly volatile
Fixed Asset Turnover1.92.981.976
Slightly volatile
Debt Ratio0.560.48910.5718
Slightly volatile
Price Sales Ratio0.110.09971.5368
Slightly volatile
Asset Turnover0.70.920.8149
Slightly volatile
Gross Profit Margin0.190.240.2556
Slightly volatile

Medirom Healthcare Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap904.1 M951.7 M5.7 B
Slightly volatile
Enterprise Value7.9 B5.1 B8.6 B
Slightly volatile

Medirom Fundamental Market Drivers

Medirom Upcoming Events

29th of May 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Medirom Healthcare Financial Statements

Medirom Healthcare investors utilize fundamental indicators, such as revenue or net income, to predict how Medirom Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue416.9 M393.3 M
Total Revenue9.5 B6 B
Cost Of Revenue7 B4.5 B
Stock Based Compensation To Revenue 0.03  0.03 
Sales General And Administrative To Revenue 0.23  0.21 
Capex To Revenue 0.06  0.06 
Revenue Per Share1.5 K891

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:
How To Invest In Medirom
Details
Is Medirom Stock a good investment?
Details
What is Medirom Healthcare's Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Medirom Healthcare Correlation against competitors.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.278
Earnings Share
0.38
Revenue Per Share
1.2 K
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.02)
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY